Aqualyx , with its clinically validated cytolytic mechanism , offers more predictable, scientifically supported results
Starting later this year and continuing into 2027 , the monthly cost of certain GLP-1s will be less than $245 for Medicare and Medicaid enrollees , with Medicare beneficiaries potentially paying a co-pay of just $50 per month
& Holscher, C
As a result, the MACE event rate varied substantially for participants assigned to placebo, being greatest in EMPA-REG OUTCOME (43.9 per 1,000 patient-years), followed by CREDENCE (38.7 per 1,000 patient-years), CANVAS (31.5 per 1,000 patient-years), and finally DECLARE-TIMI 58 (24.2 per 1,000 patient-years)
May 16 2023;25(3)doi:10.4088/PCC.22m03344